Findings

What do systematic reviews say?

2,191 questions · 2,354 findings · 362 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 323 · 13.7%GRADE not reported 382 · 16.2%Very low 555 · 23.6%Low 597 · 25.4%Moderate 345 · 14.7%High 152 · 6.5%

Dietary interventions vs usual care

Change in DLQI score (LOCF) · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 36 participants
Moderate

Dietary interventions vs usual care

Change in BMI · psoriasis

1 finding from 1 review

Lifestyle changes for treating psoriasis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 78 participants
Moderate

Psychological therapies vs controls

Migraine frequency Number of attacks · adults with migraine

1 finding from 1 review

Psychological therapies for the prevention of migraine in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 681 participants
Very low

Psychological therapies vs controls

Migraine intensityc Lower numbers = lower migraine intensity · adults with migraine

1 finding from 1 review

Psychological therapies for the prevention of migraine in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 685 participants
Very low

Psychological therapies vs controls

Moodd Lower numbers = lower reported depression, anxiety and distress symptoms · adults with migraine

1 finding from 1 review

Psychological therapies for the prevention of migraine in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 432 participants
Very low

Psychological therapies vs controls

Migraine‐related disabilitye Lower numbers = lower reported migraine‐related disability · adults with migraine

1 finding from 1 review

Psychological therapies for the prevention of migraine in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 952 participants
Very low

Biofeedback plus standard therapy vs sham biofeedback plus standard therapy

Abdominal pain · people with irritable bowel syndrome

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Biofeedback vs counseling

Abdominal pain · people with irritable bowel syndrome

1 finding from 1 review

Biofeedback for treatment of irritable bowel syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 29 participants
Low

Group 1 Pulmonary arterial hypertension ‐ PDE5i vs placebo

QoL · pulmonary arterial hypertension

1 finding from 1 review

Phosphodiesterase 5 inhibitors for pulmonary hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 163 participants
GRADE not reported

Yoga vs an active intervention

Bothersomeness of symptoms at short term (6 weeks) Measured by the Overactive Bladder Symptom and Quality of Life‐Short Form (OABq‐SF) (lower = better) · women with urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low

Yoga vs no specific active intervention

Quality of life (IIQ scores) · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Yoga vs no specific active intervention

Bothersomeness of symptoms at short term (6 weeks) Measured by Urogenital Distress Inventory 6 (UDI‐6) (lower = better) · women with either stress‐predominant or urge‐predominant urinary incontinence

1 finding from 1 review

Yoga for treating urinary incontinence in women 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low

Systemic corticosteroids vs placebo

Breathlessness (dyspnoea) at 1 week (intensity) Scale 0–10; lower score = less breathlessness · adults with cancer‐related breathlessness (dyspnoea)

1 finding from 1 review

Systemic corticosteroids for the management of cancer‐related breathlessness (dyspnoea) in adults 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 114 participants
Very low

IStent in combination with phacoemulsification vs phacoemulsification alone

Mean change in number of IOP‐lowering drops from baseline · open‐angle glaucoma

1 finding from 1 review

Ab interno trabecular bypass surgery with iStent for open‐angle glaucoma 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 282 participants
Very low

IStent (or iStent inject) vs medical therapy

Mean change in number of IOP‐lowering drops from baseline · open‐angle glaucoma

The review found no eligible studies for this question.

1 finding from 1 review

Ab interno trabecular bypass surgery with iStent for open‐angle glaucoma 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Selexipag vs placebo

Cardiac index · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Moderate

Selexipag vs placebo

RAP · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Moderate

Selexipag vs placebo

Dyspnea · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Moderate

Prostacyclin vs control

Cardiac index · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 868 participants
Low

Prostacyclin vs control

RAP · pulmonary arterial hypertension

1 finding from 1 review

Prostacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1060 participants
Moderate